cdmo.directory
← Compare landing

Dipharma vs Flamma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/flammagroup

CategoryDipharmaFlamma
Listed sitecdmocdmo
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • HPAPI Manufacturing (High-Potency)
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • API Synthesis & Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
  • Headquarters, Chignolo d'Isola, Bergamo, Italy
  • Isso, Isso, Lombardy, Italy
  • Bulciago, Bulciago, Lombardy, Italy
  • Dalian, Dalian, Liaoning, China
  • Malvern, Malvern, Pennsylvania, USA
  • Boston, Boston, Massachusetts, USA
  • Paris, Paris, Île-de-France, France
CertificationsData not yet provided.
  • FDA · Identifier: cGMP inspected
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.